Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Robert L. Huang"'
Publikováno v:
Circulation. 125:958-965
A 38-year-old man presents to his primary care physician for follow-up and review of the results of a 24-hour ambulatory monitor that was placed after an emergency department evaluation for palpitations and chest pain 2 days earlier. He had been hosp
Autor:
Christianne L. Roumie, Patricia Gideon, Robert L. Huang, Lisa A. Kaltenbach, Edward F. Mitchel, Marie R. Griffin, Shannon M. Stratton, Neesha N. Choma
Publikováno v:
Pharmacoepidemiology and Drug Safety. 18:1064-1071
Purpose Studies of non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular events using administrative data require identification of incident acute myocardial infarctions (AMIs) and information on whether confounders differ by NSAID status
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 2:392-398
Background— We implemented a quality improvement initiative to improve hypertension care at Veterans Affairs–Tennessee Valley Healthcare System. Methods and Results— We implemented multiple interventions among 2 teaching hospitals, 5 community-
Publikováno v:
Current Cardiology Reviews. 3:1-9
Heart failure carries significant morbidity and mortality burden, with median survival from onset of symptoms been reported as low as 1.7 years among men and 3.2 years among women. It is the only major cardiovascular disease which is increasing in in
Autor:
Mary Alice Nading, Carrie Giesberg, Javed Butler, Robert L. Huang, Jennifer Listerman, Joann Goring
Publikováno v:
Congestive Heart Failure. 12:206-210
Therapeutic target with beta blockers in heart failure, i.e., target heart rate reduction or beta-blocker dose, is controversial. To resolve this controversy, the authors studied 152 heart failure patients on beta blockers who were divided into four
Publikováno v:
Current Cardiology Reviews. 2:79-88
For both, the therapeutic decision making and also for the patients and their families to make appropriate personal life plans, determination of outcomes in patients with heart failure remains one of the most important goals of therapy. This however
Autor:
Eric J. Thomassee, Jae Yoon Park, Robert L. Huang, Carol Scott, David J. Maron, Joseph L. Fredi
Publikováno v:
Critical pathways in cardiology. 11(4)
The latest American College of Cardiology/American Heart Association guidelines recommend primary percutaneous coronary intervention (PCI) in acute ST-elevation myocardial infarction (STEMI) patients within 90 minutes from presentation to the emergen
Autor:
Ehab S, Kasasbeh, Babar, Parvez, Robert L, Huang, Michele Marie, Hasselblad, Mark D, Glazer, Joseph G, Salloum, John H, Cleator, David X, Zhao
Publikováno v:
The Journal of invasive cardiology. 24(11)
To determine whether radial artery access is associated with a reduction in fluoroscopy time, procedure time, and other procedural variables over a 27-month period during which the radial artery approach was incorporated in a single academic Medical
Autor:
Sunil, Kripalani, Christianne L, Roumie, Anuj K, Dalal, Courtney, Cawthon, Alexandra, Businger, Svetlana K, Eden, Ayumi, Shintani, Kelly Cunningham, Sponsler, L Jeff, Harris, Cecelia, Theobald, Robert L, Huang, Danielle, Scheurer, Susan, Hunt, Terry A, Jacobson, Kimberly J, Rask, Viola, Vaccarino, Tejal K, Gandhi, David W, Bates, Mark V, Williams, Jeffrey L, Schnipper, Daniel J, Cobaugh
Publikováno v:
Annals of internal medicine. 157(1)
Clinically important medication errors are common after hospital discharge. They include preventable or ameliorable adverse drug events (ADEs), as well as medication discrepancies or nonadherence with high potential for future harm (potential ADEs).T
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 4
Background: Door to balloon time (D2B) ≤ 90 min reduces mortality in STEMI. Although many articles outline how to achieve a D2B ≤ 90 min, few address how to create a reliable D2B process longitudinally. Methods: We engaged in an institution-wide